Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:22 pm Purchase |
2024-12-31 | 13G | Vincerx Pharma, Inc. VINC |
Armistice Capital, LLC | 4,475,121 9.990% |
4,475,121 (New Position) |
Filing History |
| 2025-02-12 08:30 am Purchase |
2024-12-31 | 13G | Vincerx Pharma, Inc. VINC |
Prosight Management LP | 111,755 4.990% |
111,755 (New Position) |
Filing History |
| 2025-02-11 7:09 pm Sale |
2024-12-31 | 13G | Vincerx Pharma, Inc. VINC |
Long Focus Capital Management LLC | 0 0.000% |
-54,938 (Position Closed) |
Filing History |
| 2024-11-14 3:39 pm Purchase |
2024-09-30 | 13G | Vincerx Pharma, Inc. VINC |
Armistice Capital, LLC | 149,655 9.990% |
149,655 (New Position) |
Filing History |
| 2024-11-14 11:57 am Sale |
2024-09-30 | 13G | Vincerx Pharma, Inc. VINC |
BANK OF AMERICA CORP BAC |
482 0.000% |
-53,662 (-99.11%) |
Filing History |
| 2024-11-13 08:32 am Sale |
2024-09-30 | 13G | Vincerx Pharma, Inc. VINC |
Prosight Management LP | 83,932 5.000% |
-40,929 (-32.78%) |
Filing History |
| 2024-05-03 09:00 am Purchase |
2024-04-25 | 13G | Vincerx Pharma, Inc. VINC |
Prosight Management LP | 124,861 9.100% |
124,861 (New Position) |
Filing History |
| 2024-04-09 5:09 pm Sale |
2024-03-28 | 13G | Vincerx Pharma, Inc. VINC |
GOLDMAN SACHS GROUP INC GS |
31,575 3.000% |
-53,908 (-63.06%) |
Filing History |
| 2024-02-14 5:10 pm Sale |
2023-12-31 | 13G | Vincerx Pharma, Inc. VINC |
Long Focus Capital Management LLC | 54,938 5.100% |
-15,810 (-22.35%) |
Filing History |
| 2024-02-13 7:05 pm Purchase |
2023-12-31 | 13G | Vincerx Pharma, Inc. VINC |
BANK OF AMERICA CORP BAC |
54,143 5.100% |
54,143 (New Position) |
Filing History |
| 2024-02-13 4:55 pm Sale |
2023-12-31 | 13G | Vincerx Pharma, Inc. VINC |
Affinity Healthcare Fund, LP | 0 0.000% |
-74,639 (Position Closed) |
Filing History |
| 2024-02-05 5:35 pm Sale |
2023-12-29 | 13G | Vincerx Pharma, Inc. VINC |
GOLDMAN SACHS GROUP INC GS |
85,483 8.000% |
-21,910 (-20.40%) |
Filing History |
| 2023-02-14 4:03 pm Purchase |
2022-12-31 | 13G | Vincerx Pharma, Inc. VINC |
Long Focus Capital Management LLC | 70,748 6.700% |
70,748 (New Position) |
Filing History |
| 2023-02-13 4:11 pm Purchase |
2022-12-31 | 13G | Vincerx Pharma, Inc. VINC |
Affinity Healthcare Fund, LP | 74,639 7.040% |
17,870 (+31.48%) |
Filing History |
| 2023-02-10 4:00 pm Sale |
2022-12-31 | 13G | Vincerx Pharma, Inc. VINC |
Rubric Capital Management LP | 19,336 1.830% |
-86,014 (-81.65%) |
Filing History |
| 2023-02-10 1:46 pm Purchase |
2023-01-31 | 13G | Vincerx Pharma, Inc. VINC |
GOLDMAN SACHS GROUP INC GS |
107,392 10.100% |
3,549 (+3.42%) |
Filing History |
| 2023-02-08 09:53 am Purchase |
2022-12-30 | 13G | Vincerx Pharma, Inc. VINC |
GOLDMAN SACHS GROUP INC GS |
103,844 9.800% |
103,844 (New Position) |
Filing History |
| 2022-12-29 5:25 pm Sale |
2022-12-29 | 13G | Vincerx Pharma, Inc. VINC |
Flynn James E | 0 0.000% |
-68,966 (Position Closed) |
Filing History |
| 2022-02-14 4:00 pm Purchase |
2021-12-31 | 13G | Vincerx Pharma, Inc. VINC |
TANG CAPITAL PARTNERS LP | 51,532 4.900% |
51,532 (New Position) |
Filing History |
| 2022-02-14 11:22 am Sale |
2021-12-31 | 13G | VINCERX PHARMA INC UNIT 1 COM VINCU |
PUTNAM INVESTMENTS LLC | 0 0.000% |
-500,000 (Position Closed) |
Filing History |